A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.
London man Dan Godley survived stage three pancreatic cancer with support from his fiancée, a dachshund puppy and groundbreaking treatment. He ...
Hina Khan says she is recovering, talks about cancer 'history' in her family: 'I never thought it is going to happen to me' ...
The Brighterside of News on MSN
New drug combination stops prostate cancer growth in phase 3 clinical trial
The Phase 3 AMPLITUDE trial led by UCL found that adding the PARP inhibitor niraparib to standard hormone therapy may slow ...
Men, breast cancer is a reality, not just a woman's disease. Rare but serious, it often goes undiagnosed due to lack of ...
Breast cancer has emerged as one of the top three cancers affecting women in India, according to a new study by the Indian ...
Cedars Sinai gets 30M to establish a specialized BRCA cancer center focusing on research, diagnosis, and treatment in Los Angeles.
13d
Mum's heartbreaking wish for her daughters after a subtle sign led to her gut-wrenching diagnosis
Bec Pickering, from Melbourne, has just one wish for her two young daughters after a devastating diagnosis turned her own ...
A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate ...
A growing number of women are turning to testosterone treatments to ease their menopause symptoms — and save their sex lives.
Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC: Horsham, Pennsylvania Wednesday, December 17, 2025, 13:00 Hrs [IST] Johnson ...
FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions in progression risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback